title: FK506 may suppress liver injury during the early period following living-related liver transplantation.
authors.affiliation: Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Kato
authors.forename: Y
authors.initials: Y
authors.lastname: Sato
authors.forename: I
authors.initials: I
authors.lastname: Kurasaki
authors.forename: S
authors.initials: S
authors.lastname: Yamamoto
authors.forename: K
authors.initials: K
authors.lastname: Hirano
authors.forename: H
authors.initials: H
authors.lastname: Nakatsuka
authors.forename: T
authors.initials: T
authors.lastname: Kobayashi
authors.forename: H
authors.initials: H
authors.lastname: Kameyama
authors.forename: T
authors.initials: T
authors.lastname: Watanabe
authors.forename: K
authors.initials: K
authors.lastname: Hatakeyama
mesh_terms: D005190:Family; D006498:Hepatectomy / Q000379:methods; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008099:Liver / Q000293:injuries / Q000473:pathology*; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D019520:Living Donors / Q000706:statistics & numerical data; D011183:Postoperative Complications / Q000517:prevention & control*; D016559:Tacrolimus / Q000627:therapeutic use*; D020858:Tissue and Organ Harvesting / Q000379:methods
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus